Article Versions Notes

Lumpuy-Castillo J, Rupérez FJ, Porto BLS, Cristóbal C, Tarín N, Huelmos AI, Alonso J, Egido J, Mahíllo-Fernández I, López-Bescós L, et al. Plasma Levels of Propionylcarnitine Improved Prediction of Heart Failure and All-Cause Mortality in Patients with Stable Coronary Artery Disease. Biomolecules. 2025; 15(1):27. https://doi.org/10.3390/biom15010027

Lumpuy-Castillo, Jairo, Francisco J. Rupérez, Brenda Lee Simas Porto, Carmen Cristóbal, Nieves Tarín, Ana Isabel Huelmos, Joaquín Alonso, Jesús Egido, Ignacio Mahíllo-Fernández, Lorenzo López-Bescós, and et al. 2025. "Plasma Levels of Propionylcarnitine Improved Prediction of Heart Failure and All-Cause Mortality in Patients with Stable Coronary Artery Disease" Biomolecules 15, no. 1: 27. https://doi.org/10.3390/biom15010027

Lumpuy-Castillo, J., Rupérez, F. J., Porto, B. L. S., Cristóbal, C., Tarín, N., Huelmos, A. I., Alonso, J., Egido, J., Mahíllo-Fernández, I., López-Bescós, L., Tuñón, J., & Lorenzo, Ó. (2025). Plasma Levels of Propionylcarnitine Improved Prediction of Heart Failure and All-Cause Mortality in Patients with Stable Coronary Artery Disease. Biomolecules, 15(1), 27. https://doi.org/10.3390/biom15010027